Volume 26, Number 9—September 2020
Perspective
Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity
Table
Study type | Brief description | Questions study could answer | Issues with interpretation and representativeness | Issues with conducting during a pandemic |
---|---|---|---|---|
Cross-sectional |
A sample of the population has serum samples collected at 1 time point |
Background cross-reactivity (if started before pandemic); current proportion of population that have been infected; proportion of population that is immune (if a correlate of protection defined); infection fatality ratio (with information on cases or deaths in the same population) |
For the different modes of collection (e.g., blood banks, residual sera, and volunteers), different issues can bias the sample included in the study that must be assessed |
Blood banks might have fewer participants, residual sera studies in hospitals might have fewer samples or over representation of severe acute respiratory syndrome coronavirus 2 infections |
Cohort |
The same persons are followed up over time, with serum samples collected at regular intervals, and information on disease in intervening periods |
Background cross-reactivity (if started before pandemic); ratio of asymptomatic to symptomatic infections; waning of antibody levels, correlates, and duration of protection; changes in infection dynamics over time |
Attrition can make analysis and interpretation difficult, biases in which participants are retained across sampling rounds |
Challenges in collecting and continuing cohort during outbreak; attrition |
Targeted populations | Populations with particularly high exposures, such as those around index patients or healthcare workers, have serum samples taken either cross-sectionally or in a targeted cohort | Attack rates; ratio of asymptomatic to symptomatic infections; proportion of population infected, correlates, and duration of protection | Targeted populations because healthcare workers might have different infection exposure rates and intensity from the general population | Potentially logistically difficult to collect samples in household studies |
1These first authors contributed equally to this article.
2These authors contributed equally to this article.
Page created: June 02, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.